STOCKHOLDERS’ EQUITY - Schedule of Inducement Plan (Details) - Inducement grant-related RSUs - Time-Based - $ / shares |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Time-Based | |||
| Beginning of period (in shares) | 50,000 | 50,000 | |
| Granted (in shares) | 0 | 0 | |
| Vested (in shares) | (18,750) | 0 | |
| Forfeited (in shares) | 0 | 0 | |
| Ending of period (in shares) | 31,250 | 50,000 | 50,000 |
| Weighted Average Grant Date Fair Value | |||
| Beginning of period (in dollars per share) | $ 2.52 | $ 2.52 | |
| Granted (in dollars per share) | 0 | 0 | |
| Forfeited (in dollars per share) | 0 | 0 | |
| Ending of period (in dollars per share) | $ 2.52 | $ 2.52 | $ 2.52 |
| Waiting average vesting period (in years) | 2 years 3 months 18 days | 2 years 9 months 18 days | 3 years 9 months 18 days |
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|